View It Now!
On Demand
DURATION: 60 minutes
COST: Complimentary
Speakers
Addressing Challenges of
NGS Data Interpretation for
Hematologic Malignancies
As next-generation sequencing (NGS) technologies continue
to rapidly enter the clinical arena, investigators are facing the
challenges of transitioning this powerful genomic tool from
a benchtop gene discovery method to a routine precision
medicine diagnostic. Moreover, the application of NGS to
hematologic malignancies has uncovered many underlying
molecular mechanisms of disease diagnosis, progression,
and response to therapeutic interventions. Yet, with the
overwhelming amount and complexity of genomic data that
NGS provides, clinicians often get mired in the analysis phase,
seeking information that enables them to efficiently utilize
the data to provide more effective treatment strategies for
their patients.
Join us for this groundbreaking Clinical OMICs roundtable
webinar, where we will discuss how NGS technologies have
aided clinicians in the diagnosis and treatment of
hematologic cancers, in addition to discussing strategies
employed to streamline the clinical interpretation.
A live Q&A; session will follow the presentations,
offering you a chance to pose questions to our
expert panelists.
Who Should Attend
• Cancer researchers
•
Scientists using next-generation sequencing
•
Clinical geneticists
•
Molecular pathologists
•
Drug development researchers
•
Oncologists
•
Bioinformaticists
Free Registration!
www.clinicalomics.com/heme
You Will Learn
• How NGS is currently being used by oncologists
and geneticists as a diagnostic, prognostic and predictive
tool for the treatment of hematologic malignancies
• Some of the main challenges in testing and clinical
interpretation and how researchers and clinicians
are successfully navigating these hurdles
•
The importance of combining NGS techniques
with other testing modalities
Andrew
Lane, M.D., Ph.D.
Physician-Scientist
Dana-Farber Cancer Institute
Gregory
Riedlinger, M.D., Ph.D.
Assistant Professor of
Pathology, Rutgers Cancer
Institute of New Jersey
Produced with support from
Webinars
Kristen
Champion, Ph.D.
Technical Director
Molecular Pathology
Laboratory, Med Fusion
Sheryl Krevsky
Elkin, Ph.D.
Scientific Director
N-of-One